Orgenesis

Orgenesis is a vertically integrated biopharmaceutical company with unique expertise and experience in the development and manufacturing of cell therapies. Orgenesis adopts a novel approach to treating diabetes by correcting dysfunctional organs with new functional tissue generated from the patient's own existing organs. Orgenesis employs molecular and cellular approaches to transform hepatocytes into functional insulin-producing cells as a treatment for diabetes. This novel therapeutic approach is referred to as Autologous Insulin Production (AIP) cell transplantation.